Sg3 Management, LLC Uni Qure N.V. Put Options Transaction History

Sg3 Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $503,736 - $759,496	27,800 New	27,800 $630,000
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $723,250 - $1.12 Million	-55,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $363,500 - $537,500	25,000 Added 83.33%	55,000 $994,000
Q4 2021 Feb 15, 2022	BUY	$20.24 - $36.01 $404,799 - $720,200	20,000 Added 200.0%	30,000 $622,000
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $130,050 - $191,100	-5,000 Reduced 33.33%	10,000 $320,000
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $438,600 - $630,450	-15,000 Reduced 50.0%	15,000 $505,000
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $530,250 - $760,050	15,000 Added 100.0%	30,000 $1.08 Million
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $539,700 - $714,900	15,000 New	15,000 $552,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.